Toggle navigation
Home
Search
Services
Blog
Contact
About
Innovative Therapies for Rheumatic and Skin Diseases-264022264
University of Cincinnati, Cincinnati, OH, United States
Search grants from University of Cincinnati
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
CD39 in Vein Graft Arterialization
Neuromodulation as a Treatment for Chemotherapy-Induced Peripheral Neuropathy
Integration of Taste and Visceral Afferent Signals
Function of Two Novel Type II Cell Proteins in Lung
Longitudinal Neurobehavioral Assessment Procedure for Preterm Infants
Recently added grants:
Spinal cord functional connectivity as a biomarker of spinal cord dysfunction
Molecular Genetics Mouse Core
Mechanisms of Visual Transduction
Physiological and perceptual examination of vision restoration
Physiology Core
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research and Development Contracts (N01)
Project #
N01AR022264-005
Application #
6994642
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2004
Total Cost
Indirect Cost
Institution
Name
University of Cincinnati
Department
Type
DUNS #
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Related projects
NIH 2005
N01 AR
Gabapentin in the Treatment of Fibromyalgia-264022264
/ University of Cincinnati
NIH 2004
N01 AR
Innovative Therapies for Rheumatic and Skin Diseases-264022264
/ University of Cincinnati
NIH 2003
N01 AR
Innovative Therapies for Rheumatic and Skin Diseases-N01AR2226
/ University of Cincinnati
NIH 2002
N01 AR
Innovative Therapies for Rheumatic and Skin Diseases-N01AR2226
/ University of Cincinnati
Publications
Arnold, Lesley M; Goldenberg, Don L; Stanford, Sharon B et al.
(2007)
Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial.
Arthritis Rheum 56:1336-44
Comments
Be the first to comment on this grant